Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 171Neoplasms 137Prostatic Neoplasms 77Lung Neoplasms 69Colorectal Neoplasms 68Motor Activity 39Uterine Cervical Neoplasms 36Pancreatic Neoplasms 30Head and Neck Neoplasms 28Ovarian Neoplasms 27Brain Neoplasms 27Carcinoma, Non-Small-Cell Lung 23Rectal Neoplasms 21Glioblastoma 21Carcinoma, Hepatocellular 21Colonic Neoplasms 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Stomach Neoplasms 16Hematologic Neoplasms 16Disease 16Depression 16Anxiety Disorders 16Papillomavirus Infections 14Melanoma 14Leukemia 14Multiple Myeloma 13Glioma 13Squamous Cell Carcinoma of Head and Neck 12Carcinoma, Renal Cell 12Urinary Bladder Neoplasms 11

Interventions

Tobacco Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Smoking Reduction × 30 days × Clear all
NCT04620915 2026-05-08

Construal Level as a Novel Pathway for Affect Regulation and Cancer Control

University of Oregon

Phase NA Completed
300 enrolled

Smoking Reduction, Neoplasms, Smoking, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡